Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
October 10, 2008
 
Industry Categories  
News by Country  
News by MSA  
Today's News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
Close Move
All Press Releases for July 17, 2007 Subscribe to this News Feed    
 

ASL Pharmacy Improves Patient Compliance by Reducing Treatment Time

Aerosol Science Laboratories has changed its proprietary formulas on certain medications, which allow them to aerosolize faster than before. Faster aerosolization translates into shorter treatment time when a patient inhales sinus medication. With shorter treatment times, patients are more likely to begin and complete their course of therapy.

Camarillo, CA (PRWEB) July 17, 2007 -- Aerosol Science Laboratories has recently minimized the treatment time to aerosolize a dose of Mometasone for sinus inhalation from 8 minutes to 3.5 minutes by adjusting its proprietary formulation. This improvement in treatment time is significant considering many physicians are prescribing two medications such as an antibiotic and an anti-inflammatory. The patient administers their medications sequentially. For more detail as to how this benefits a patient, following are details of a recent case:

ASL_logo_med.jpg

Patient: Female, Age 46
Dx: 473.9 Chronic Sinusitis
Culture: Pseudomonas Aeruginosa

#1 Medication: ASL Tobramycin Inhalation Solution

  • This aminoglycoside disrupts protein synthesis in gram-negative
  • bacteria such as Pseudomonas Aeruginosa.
  • Alcohol free
  • Ph = 6.1
  • Dose 125 mg/2ml
  • Tx time = 3.5 minutes per dose

#2 Medication: ASL Mometasone Inhalation Solution
  • This corticosteroid reduces tissue inflammation. Mometasone is the
  • active ingredient found in Nasonex™ safely used by over 6 million people.
  • Alcohol Free
  • Ph = 4.4
  • Dose 0.6 mg/2ml
  • Tx time = 3.0 minutes per dose
Administration: The patient inhaled both aerosolized intranasal medications TID for 21 days. Total treatment time per day was less than 20 minutes.

Results: Aerosol Science Laboratories reduced total treatment time by 4.73 hours during the 21-day treatment period. This large reduction in the time necessary for a patient to administer their medications should result in a significant improvement in patient compliance for this type of therapy.

If you would like more information regarding specific treatment times on other individual medications dispensed by ASL or if you have any other questions regarding inhalant sinus therapy, please feel free to contact Aerosol Science Laboratories and ASL Pharmacy at 866-552-7579 or visit our website at ASLRx or Sinus Science. Aerosol Science Laboratories and ASL Pharmacy specialize in the treatment of Sinusitis and Allergic Rhinitis.

###

Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/TG92ZS1TcXVhLUNyYXMtUGlnZy1UaGlyLVplcm8=

Technorati Tags

Bookmark -  Del.icio.us | Digg | Furl It | Spurl | RawSugar | Simpy | Shadows | Blink It | My Web


Other Releases by this Member
OPTIONS
Printer Friendly Version
Download PDF Version
Download Reader Version
BlogThis
ShareIt

Share The News

Submit this press release easily to any of these major bookmarking and social media sites.

CONTACT INFORMATION
CAL TARRANT
Aerosol Science Laboratories Inc.
866-552-7579
Email us Here
ATTACHED FILES

Aerosol Science Laboratories Clean Room (ISO 5)
Aerosol Science Laboratories exceeds industry standards for sterility by preparing all medications inside an ISO Class 5 cleanroom.

Aerosol Science Laboratories Logo
Aerosol Science Laboratories Pharmacy Logo (ASL)

Sinus Science Nebulizer
The Sinus Science nebulizer weighs three ounces, fits in the palm of your hand and is silent, lightweight and portable.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these release. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright